{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:43:07Z","timestamp":1791178987273,"version":"4.1.0"},"reference-count":327,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.ghir.2004.06.001","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T14:22:43Z","timestamp":1090419763000},"page":"337-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":262,"title":["Free insulin-like growth factors \u2013 measurements and relationships to growth hormone secretion and glucose homeostasis"],"prefix":"10.1016","volume":"14","author":[{"given":"Jan","family":"Frystyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2004.06.001_BIB1","first-page":"80","article-title":"Nutritional regulation of the insulin-like growth factors","volume":"15","author":"Thissen","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB2","first-page":"3","article-title":"Insulin-like growth factors and their binding proteins: biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB3","first-page":"801","article-title":"Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions","volume":"18","author":"Rajaram","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB4","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB5","series-title":"Contemporary Endocrinology: The IGF System","first-page":"577","article-title":"Metabolic effects of IGFs","author":"Zapf","year":"1999"},{"key":"10.1016\/j.ghir.2004.06.001_BIB6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1210\/edrv.21.3.0399","article-title":"The effects of insulin-like growth factors on tumorigenesis and neoplastic growth","volume":"21","author":"Khandwala","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/diabetes.50.3.637","article-title":"A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction","volume":"50","author":"Vaessen","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd917","article-title":"Structural biology of insulin and IGF1 receptors: implications for drug design","volume":"1","author":"De Meyts","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ghir.2004.06.001_BIB9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000066230","article-title":"The role of the IGF system in cancer: from basic to clinical studies and clinical applications","volume":"63","author":"Moschos","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000027563.44593.CC","article-title":"Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study","volume":"106","author":"Juul","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2004.06.001_BIB11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/edrv-16-2-143","article-title":"Molecular and cellular aspects of the insulin-like growth factor-I receptor","volume":"16","author":"LeRoith","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001","volume":"22","author":"LeRoith","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/er.2001-0033","article-title":"Cellular actions of the insulin-like growth factor binding proteins","volume":"23","author":"Firth","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB14","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.06.001_BIB15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/15321819408009577","article-title":"Measurement of free insulin-like growth factor-I using immunoradiometric assay","volume":"15","author":"Takada","year":"1994","journal-title":"J. Immunoassay"},{"key":"10.1016\/j.ghir.2004.06.001_BIB16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-5793(94)00602-4","article-title":"Free insulin-like growth factors (IGF-I and IGF-II) in human serum","volume":"348","author":"Frystyk","year":"1994","journal-title":"FEBS Lett."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.06.001_BIB17","first-page":"84","article-title":"Free insulin-like growth factor I: are we hunting a ghost?","volume":"55","author":"Bang","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00400998","article-title":"Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance","volume":"34","author":"Schoenle","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/BF00404081","article-title":"The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus","volume":"36","author":"Cheetham","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/BF02374481","article-title":"Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects","volume":"36","author":"Laager","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB21","first-page":"1518","article-title":"The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity","volume":"85","author":"Clemmons","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.06.001_BIB22","first-page":"68","article-title":"Inhibition of the insulin-like growth factor (IGF)-IGF-binding protein interaction","volume":"55","author":"Baxter","year":"2001","journal-title":"Horm. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.06.001_BIB23","first-page":"73","article-title":"Commercial assays available for insulin-like growth factor I and their use in diagnosing growth hormone deficiency","volume":"55","author":"Clemmons","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB24","first-page":"753","article-title":"Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates","volume":"121","author":"Guler","year":"1989","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB25","first-page":"E130","article-title":"Diverse effects of insulin-like growth factor I on glucose lipid and amino acid metabolism","volume":"262","author":"Boulware","year":"1992","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB26","first-page":"51","article-title":"Measurement of free form of insulin-like growth factor I in human plasma","volume":"1","author":"Hizuka","year":"1991","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2004.06.001_BIB27","unstructured":"P.D. Lee, D. Powell, B. Baker, F. Liu, G. Mathew, I. Levitsky, O.D. Gutierrez, R.L. Hintz, Characterization of a direct, non-extraction immunoradiometric assay for free IGF-I, Proc. 76th Ann. Meeting Endocrine Soc. 1994, Abstract 939"},{"key":"10.1016\/j.ghir.2004.06.001_BIB28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/00365518609083686","article-title":"Ultrafiltration method for direct radioimmunoassay measurement of free thyroxine and free tri-iodothyronine in serum","volume":"46","author":"Weeke","year":"1986","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1210\/edrv-11-1-5","article-title":"Measurement of free hormone in blood","volume":"11","author":"Ekins","year":"1990","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB30","first-page":"169","article-title":"Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II","volume":"5","author":"Frystyk","year":"1995","journal-title":"Growth Regul."},{"key":"10.1016\/j.ghir.2004.06.001_BIB31","first-page":"E967","article-title":"Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrisic bioactivities","volume":"278","author":"Baxter","year":"2000","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB32","first-page":"1376","article-title":"Alteration in insulin-like growth factor binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure","volume":"79","author":"Lee","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB33","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1046\/j.1523-1755.1999.00798.x","article-title":"Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure","volume":"56","author":"Frystyk","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2004.06.001_BIB34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1054\/ghir.2001.0197","article-title":"Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay","volume":"11","author":"Frystyk","year":"2001","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB35","first-page":"2497","article-title":"Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency","volume":"82","author":"Juul","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.1996.711531.x","article-title":"Serum concentrations of free and total insulin-like growth factor-I IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty","volume":"44","author":"Juul","year":"1996","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB38","first-page":"172","article-title":"Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective","volume":"23","author":"Patel","year":"2000","journal-title":"Clin. Invest. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.06.001_BIB39","first-page":"100","article-title":"Normal values of insulin-like growth factor I and their clinical utility in adults","volume":"55","author":"Strasburger","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1258\/0004563011900678","article-title":"Insulin-like growth factor I measurement in diagnosis and management of acromegaly","volume":"38","author":"Peacey","year":"2001","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(94)90181-3","article-title":"Diagnosis of growth-hormone deficiency in adults","volume":"343","author":"Hoffman","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.06.001_BIB42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1507\/endocrj.49.379","article-title":"Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3","volume":"49","author":"Fukuda","year":"2002","journal-title":"Endocr. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB43","first-page":"423","article-title":"Growth hormone the insulin-like growth factor system, and the kidney","volume":"17","author":"Feld","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.0800807","article-title":"Growth hormone in obesity","volume":"23","author":"Scacchi","year":"1999","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2004.06.001_BIB45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-2007-978716","article-title":"Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus","volume":"31","author":"Bereket","year":"1999","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB46","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1043-2760(00)00362-3","article-title":"Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor","volume":"12","author":"Kojima","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(02)01432-2","article-title":"Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity","volume":"440","author":"Muccioli","year":"2002","journal-title":"Eur. J. Phar."},{"key":"10.1016\/j.ghir.2004.06.001_BIB49","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1210\/jcem-70-5-1347","article-title":"Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex","volume":"70","author":"Baxter","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB50","first-page":"1610","article-title":"Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion","volume":"76","author":"Blum","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB51","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1210\/jcem.83.12.5311","article-title":"The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release diurnal variation, circulating concentrations in healthy subjects and diagnostic use in patients with growth hormone deficiency","volume":"83","author":"Juul","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/joe.0.1700063","article-title":"The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system","volume":"170","author":"Boisclair","year":"2001","journal-title":"J. Endocrinol."},{"issue":"Suppl. 4","key":"10.1016\/j.ghir.2004.06.001_BIB53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0026-0495(95)90219-8","article-title":"Free insulin-like growth factors in human obesity","volume":"44","author":"Frystyk","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB54","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2265.1998.00300.x","article-title":"Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels","volume":"48","author":"Janssen","year":"1998","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB55","first-page":"82","article-title":"Serum free insulin-like growth factor I (IGF-I) total IGF-I, and IGF- binding protein-3 concentrations in normal children and children with hormone deficiency","volume":"84","author":"Kawai","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB56","first-page":"E846","article-title":"Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes","volume":"260","author":"Boni Schnetzler","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0026-0495(81)90052-4","article-title":"The effect of fasting on liver receptors for prolactin and growth hormone","volume":"30","author":"Baxter","year":"1981","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB58","first-page":"4712","article-title":"Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation","volume":"85","author":"Leung","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB59","first-page":"267","article-title":"The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes","volume":"77","author":"Wurzburger","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/153537020222700301","article-title":"Growth hormone-induced alterations in the insulin-signaling system","volume":"227","author":"Dominici","year":"2002","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB61","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1210\/endo.135.5.7525258","article-title":"Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats","volume":"135","author":"Cox","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB62","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004670000362","article-title":"Effects of IGFBP-2 overexpression in vitro and in vivo","volume":"14","author":"Wolf","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1520-7560(199909\/10)15:5<314::AID-DMRR56>3.0.CO;2-E","article-title":"Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes","volume":"15","author":"Frystyk","year":"1999","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB64","first-page":"E245","article-title":"Changes in the circulating IGF system during short-term fasting and refeeding in rats","volume":"277","author":"Frystyk","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB65","first-page":"2324","article-title":"Development and clinical evaluation of a novel immunoassay for the binary complex of insulin-like growth factor-I (IGF-I) and IGF-binding protein-1 in human serum","volume":"84","author":"Frystyk","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB66","first-page":"1561","article-title":"Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 1 gene transcription by hormones and provision of amino acids in rat hepatocytes","volume":"7","author":"Pao","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB67","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3181\/00379727-216-44182","article-title":"Insulin-like growth factor binding protein-1: recent findings and new directions","volume":"216","author":"Lee","year":"1997","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB68","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0006-291X(92)92307-J","article-title":"Post-transcriptional regulation of insulin-like growth factor binding protein-2 mRNA in diabetic rat liver","volume":"189","author":"Ooi","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2004.06.001_BIB69","first-page":"1355","article-title":"Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans","volume":"74","author":"Conover","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB70","first-page":"872","article-title":"Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1) IGFBP-3 and IGF-I in insulin-dependent diabetes","volume":"79","author":"Brismar","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB71","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1210\/mend-4-9-1320","article-title":"Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes","volume":"4","author":"Boni-Schnetzler","year":"1990","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB72","first-page":"2324","article-title":"Changes in free insulin-like growth factor-I and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes","volume":"84","author":"Attia","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1210\/jcem-73-4-727","article-title":"Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects","volume":"73","author":"Clemmons","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB74","first-page":"2266","article-title":"Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone","volume":"82","author":"Lee","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB75","first-page":"3124","article-title":"The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults","volume":"82","author":"Frystyk","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB76","first-page":"E507","article-title":"Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline","volume":"273","author":"Frystyk","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2265.1999.00694.x","article-title":"Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay","volume":"50","author":"Van Doorn","year":"1999","journal-title":"Clin Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB78","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jcem.87.1.8151","article-title":"Molecular distribution of IGF binding protein-5 in human serum","volume":"87","author":"Baxter","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2265.2001.01248.x","article-title":"Plasma levels of insulin-like growth factor binding protein-4 (IGFBP-4) under normal and pathological conditions","volume":"54","author":"Van Doorn","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1440-1746.2002.02703.x","article-title":"Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation","volume":"17","author":"Kim","year":"2002","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1523-1755.2000.00862.x","article-title":"Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy","volume":"57","author":"Jehle","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2004.06.001_BIB82","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0953-6205(02)00183-8","article-title":"Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients","volume":"14","author":"Jehle","year":"2003","journal-title":"Eur.J. Intern. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB83","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1074\/jbc.273.11.6074","article-title":"Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit","volume":"273","author":"Twigg","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.1994.tb03788.x","article-title":"The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients","volume":"41","author":"Juul","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1210\/jcem.82.1.3679","article-title":"High ratios of free to total insulin-like growth factor-I in early infancy","volume":"82","author":"Hasegawa","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB86","first-page":"2809","article-title":"Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1) and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus","volume":"82","author":"Janssen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X","article-title":"Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation","volume":"13","author":"Yu","year":"1999","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ghir.2004.06.001_BIB88","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","article-title":"Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men","volume":"73","author":"Iranmanesh","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB89","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","article-title":"Overweight and obesity in the United States: prevalence and trends, 1960-1994","volume":"22","author":"Flegal","year":"1998","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2004.06.001_BIB90","first-page":"40","article-title":"Short-term tools to measure responsiveness to growth hormone replacement","volume":"55","author":"J\u00f8rgensen","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB91","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1054\/ghir.2001.0203","article-title":"Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency","volume":"11","author":"Sizonenko","year":"2001","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB93","doi-asserted-by":"crossref","unstructured":"Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement for the GH Research Society, J. Pediatr. Endocrinol. Metab. 14 (2001) 377\u2013382","DOI":"10.1515\/JPEM.2001.14.4.377"},{"key":"10.1016\/j.ghir.2004.06.001_BIB94","doi-asserted-by":"crossref","unstructured":"Growth Hormone Research Society, Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the GH Research Society workshop on adult growth hormone deficiency, J. Clin. Endocrinol. Metab. 83 (1998) 379\u2013381","DOI":"10.1210\/jc.83.2.379"},{"key":"10.1016\/j.ghir.2004.06.001_BIB95","first-page":"1467","article-title":"Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues","volume":"85","author":"Hoeck","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB96","first-page":"3323","article-title":"Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children","volume":"81","author":"Ghigo","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB97","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.1990.tb11675.x","article-title":"Assay-dependent results of immunoassayable spontaneous 24-h growth hormone secretion in short children","volume":"370","author":"Granada","year":"1990","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.ghir.2004.06.001_BIB98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB99","first-page":"3001","article-title":"Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults","volume":"86","author":"Marzullo","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB100","first-page":"1294","article-title":"Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children","volume":"77","author":"Smith","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB101","first-page":"2646","article-title":"Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects","volume":"80","author":"Hilding","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB102","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/jcem.83.4.4686","article-title":"No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis","volume":"83","author":"Skj\u00e6rb\u00e6k","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB103","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1507\/endocrj.46.717","article-title":"Absence of proteolysis of insulin-like growth factor binding protein-3 in serum from patients with growth hormone deficiency","volume":"46","author":"Yamada","year":"1999","journal-title":"Endocr. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB104","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1172\/JCI112742","article-title":"Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma","volume":"78","author":"Baxter","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3476(86)80112-3","article-title":"Insulin-like growth factors I and II in evaluation of growth retardation","volume":"109","author":"Rosenfeld","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ghir.2004.06.001_BIB106","first-page":"4104","article-title":"Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease","volume":"85","author":"Fernholm","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB107","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1530\/eje.0.1350672","article-title":"Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults","volume":"135","author":"Skj\u00e6rb\u00e6k","year":"1996","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB108","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/endo-128-2-689","article-title":"Enhanced expression of insulin-like growth factor-binding protein-1 in the fasted rat: the effects of insulin and growth hormone administration","volume":"128","author":"Murphy","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1054\/ghir.1998.0087","article-title":"Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults","volume":"9","author":"N\u00f8rrelund","year":"1999","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB110","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB111","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1210\/jcem.87.5.8460","article-title":"The effects of short-term administration of two low doses versus the standard GH replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults","volume":"87","author":"Yuen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB112","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement","volume":"85","author":"Giustina","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB113","first-page":"2284","article-title":"A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes","volume":"130","author":"Okada","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB114","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s001250051515","article-title":"Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease","volume":"43","author":"Flyvbjerg","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB116","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/jc.2002-011841","article-title":"Guidelines for acromegaly management","volume":"87","author":"Melmed","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB117","first-page":"3808","article-title":"Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly","volume":"83","author":"Freda","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/jcem-67-1-69","article-title":"Plasma insulin-like growth factor-I\/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion","volume":"67","author":"Barkan","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB119","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2265.1995.tb02651.x","article-title":"Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion","volume":"42","author":"Bates","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2265.1993.tb02139.x","article-title":"Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly","volume":"38","author":"Dobrashian","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2004.06.001_BIB121","first-page":"S9","article-title":"Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis","volume":"155","author":"van der Lely","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB122","first-page":"1091","article-title":"Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3","volume":"86","author":"Arosio","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB123","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1054\/ghir.2001.0254","article-title":"Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly","volume":"11","author":"Sneppen","year":"2001","journal-title":"Growth Horm. IGF Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2004.06.001_BIB124","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0026-0495(95)90304-6","article-title":"Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients","volume":"44","author":"Kaal","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB125","first-page":"1459","article-title":"Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action","volume":"75","author":"Ezzat","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1677\/joe.0.1470545","article-title":"Stimulation of hepatic insulin-like growth factor-binding protein-1 and -3 gene expression by octreotide in rats","volume":"147","author":"Flyvbjerg","year":"1995","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB127","first-page":"141","article-title":"Dose-dependent stimulation of insulin-like growth factor-binding protein-1 by lanreotide","volume":"78","author":"Wolthers","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB128","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant","volume":"342","author":"Trainer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB129","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","article-title":"Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist","volume":"358","author":"van der Lely","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.06.001_BIB130","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jcem.87.4.8432","article-title":"A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal","volume":"87","author":"Parkinson","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1096-6374(02)00083-7","article-title":"Growth hormone receptor antagonist improves insulin resistance in acromegaly","volume":"12","author":"Rose","year":"2002","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB132","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000183763","article-title":"The effect of simple obesity on growth and growth hormone","volume":"40","author":"Vanderschueren-Lodeweyckx","year":"1993","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB133","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0026-0495(94)90099-X","article-title":"The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone","volume":"43","author":"Rasmussen","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB134","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diab.24.11.977","article-title":"Twenty-four-hour serum growth hormone levels in maturity-onset diabetics","volume":"24","author":"Kjeldsen","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB135","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/0026-0495(78)90086-0","article-title":"Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics","volume":"27","author":"Christensen","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB136","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/1043-2760(94)90005-1","article-title":"Growth hormone neuroregulation in diabetes mellitus","volume":"5","author":"Giustina","year":"1994","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB137","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diacare.21.8.1330","article-title":"Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2004.06.001_BIB138","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/S0140-6736(00)03322-5","article-title":"Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes","volume":"356","author":"Spyer","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.06.001_BIB139","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1096-6374(98)80098-1","article-title":"Insulin-like growth factor-I and diabetes. A review","volume":"8","author":"Simpson","year":"1998","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2337\/diacare.24.2.328","article-title":"Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance","volume":"24","author":"Bluher","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2004.06.001_BIB141","first-page":"1467","article-title":"The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity","volume":"83","author":"Attia","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2004.06.001_BIB143","first-page":"2076","article-title":"Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction","volume":"82","author":"Argente","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1515\/JPEM.1999.12.2.139","article-title":"Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children","volume":"12","author":"Park","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB146","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s001250051561","article-title":"Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test","volume":"43","author":"Albareda","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB147","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s001250051623","article-title":"Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations","volume":"44","author":"Heald","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB148","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1054\/ghir.2000.0140","article-title":"Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins","volume":"10","author":"Feldmann","year":"2000","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB149","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001250050951","article-title":"Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia","volume":"41","author":"Frystyk","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2265.2000.00876.x","article-title":"Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency","volume":"52","author":"Skj\u00e6rb\u00e6k","year":"2000","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB151","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2007-978685","article-title":"IGF-I and IGFBP-3-expression in cultured human preadipocytes and adipocytes","volume":"32","author":"Wabitsch","year":"2000","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB152","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/endo.131.5.1425415","article-title":"Rat somatotroph insulin-like growth factor-II (IGF-II) signaling: role of the IGF-I receptor","volume":"131","author":"Weber","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB153","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/eje.0.1440251","article-title":"Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH","volume":"144","author":"Maccario","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1530001","article-title":"The serum growth hormone binding protein: pregnant with possibilities","volume":"153","author":"Barnard","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jcem.85.3.6461","article-title":"Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function?","volume":"85","author":"Amit","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB156","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/diab.20.4.239","article-title":"Diurnal serum growth hormone levels in poorly and well controlled juvenile diabetics","volume":"20","author":"Johansen","year":"1971","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB157","series-title":"Growth Hormone and Insulin-like Growth Factor I in Human and Experimental Diabetes","first-page":"77","article-title":"The role of growth hormone in the regulation of human fuel metabolism","author":"M\u00f8ller","year":"1993"},{"key":"10.1016\/j.ghir.2004.06.001_BIB158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8227(94)90155-4","article-title":"Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion","volume":"25","author":"Shishko","year":"1994","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ghir.2004.06.001_BIB159","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1996.7760786.x","article-title":"Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children","volume":"45","author":"Bereket","year":"1996","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.930251","article-title":"The relationship between the IGF-I system and its binding proteins and microvascular reactivity in Type 1 diabetes mellitus","volume":"51","author":"Krsek","year":"2002","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB161","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1464-5491.2003.00921.x","article-title":"The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients","volume":"20","author":"Frystyk","year":"2003","journal-title":"Diabetes Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB162","first-page":"41","article-title":"Insulin-like growth factors and their binding proteins in children with IDDM","volume":"85","author":"Wacharasindhu","year":"2002","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.ghir.2004.06.001_BIB163","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF00277413","article-title":"Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats","volume":"31","author":"Flyvbjerg","year":"1988","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB164","series-title":"Growth Hormone and Insulin-like Growth Factor I in Human and Experimental Diabetes","first-page":"203","article-title":"Diabetic retinopathy: an analysis of the possible pathogenic roles of growth hormone and insulin-like growth factor I","author":"Sharp","year":"1993"},{"key":"10.1016\/j.ghir.2004.06.001_BIB165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM198309013090904","article-title":"Insulin-like growth factors. Studies in diabetics with and without retinopathy","volume":"309","author":"Merimee","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB166","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1464-5491.1988.tb01005.x","article-title":"Serum IGF-I concentration in diabetic retinopathy","volume":"5","author":"Hyer","year":"1988","journal-title":"Diabetes Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB167","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2337\/diab.44.2.161","article-title":"Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy?","volume":"44","author":"Wang","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB168","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bjo.81.2.168b","article-title":"Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome","volume":"81","author":"Chantelau","year":"1997","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB169","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2007-1009140","article-title":"Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII)","volume":"21","author":"Hyer","year":"1989","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB170","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0140-6736(97)22043-X","article-title":"Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?","volume":"350","author":"M\u00f8ller","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2004.06.001_BIB171","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB172","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/diacare.26.5.1456","article-title":"Low IGF-I and Elevated Testosterone During Puberty in Subjects With Type 1 Diabetes Developing Microalbuminuria in Comparison to Normoalbuminuric Control Subjects: The Oxford Regional Prospective Study","volume":"26","author":"Amin","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2004.06.001_BIB173","first-page":"S106","article-title":"Derangements of the somatotropic hormone axis in chronic renal failure","volume":"58","author":"T\u00f6nshoff","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ghir.2004.06.001_BIB174","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.1.6062.679","article-title":"Somatomedin in growth disorders and chronic renal insufficiency in children","volume":"1","author":"Schwalbe","year":"1977","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB175","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1210\/jcem-59-4-764","article-title":"Somatomedin inhibitor in uremia","volume":"59","author":"Phillips","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB176","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01453697","article-title":"Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uraemia","volume":"5","author":"Blum","year":"1991","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB177","first-page":"596","article-title":"Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group","volume":"84","author":"Powell","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB178","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1203\/00006450-199302000-00011","article-title":"Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum","volume":"33","author":"Powell","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB179","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1210\/endo.137.8.8754741","article-title":"A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin","volume":"137","author":"Lalou","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB180","first-page":"2684","article-title":"Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate","volume":"80","author":"T\u00f6nshoff","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB181","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0026-0495(85)90213-6","article-title":"Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique","volume":"34","author":"Schmitz","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB182","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/ki.1997.268","article-title":"Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group","volume":"51","author":"Powell","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2004.06.001_BIB183","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1210\/jcem.82.9.4261","article-title":"Impaired postprandial regulation of insulin-like growth factor binding protein-1 in children with chronic renal failure","volume":"82","author":"Haffner","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB184","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ki.1996.164","article-title":"Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failure","volume":"49","author":"Rabkin","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2004.06.001_BIB185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1515\/JPEM.1997.10.2.197","article-title":"Growth hormone treatment in growth retarded children with end stage renal failure: effect on free\/dissociable IGF-I levels","volume":"10","author":"Bereket","year":"1997","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB186","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000045564","article-title":"Evaluation of IGF system component levels and mitogenic activity of uremic serum on normal human osteoblasts","volume":"84","author":"Wagner","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.ghir.2004.06.001_BIB187","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jcem.74.4.1548337","article-title":"Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men","volume":"74","author":"Hartman","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB188","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2265.1993.tb02377.x","article-title":"The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting","volume":"39","author":"Cotterill","year":"1993","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB189","first-page":"960","article-title":"Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects","volume":"78","author":"Bang","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB190","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jcem-55-5-999","article-title":"Insulin-like growth factors in the fed and fasted states","volume":"55","author":"Merimee","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB191","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.0.1460203","article-title":"Ghrelin drives GH secretion during fasting in man","volume":"146","author":"Muller","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB192","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1210\/jcem.87.6.8601","article-title":"Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1","volume":"87","author":"Katz","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB193","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/jcem-67-6-1231","article-title":"Serum concentrations of insulin-like growth factor II are not changed by short-term fasting and refeeding","volume":"67","author":"Davenport","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB194","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1365-2265.2003.01699.x","article-title":"Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity","volume":"58","author":"Grottoli","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB195","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/sj.ijo.0801671","article-title":"Effects of 36 hour fasting on GH\/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency","volume":"25","author":"Maccario","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ghir.2004.06.001_BIB196","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1515\/JPEM.2001.14.5.459","article-title":"Update on endocrine disturbances in anorexia nervosa","volume":"14","author":"St\u00f8ving","year":"2001","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB197","first-page":"2084","article-title":"Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation","volume":"82","author":"Argente","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB198","first-page":"762","article-title":"The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins","volume":"75","author":"Counts","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB199","first-page":"1346","article-title":"Low serum levels of free and total insulin-like growth factor I (IGF-I) in patients with anorexia nervosa are not associated with increased IGF- binding protein-3 proteolysis","volume":"84","author":"St\u00f8ving","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1099-0895(199610)12:3<195::AID-DMR164>3.0.CO;2-G","article-title":"Insulin-like growth factor I: physiology, metabolic effects and clinical uses","volume":"12","author":"Froesch","year":"1996","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB201","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1463-1326.2000.00123.x","article-title":"Insulin-like growth factor-I for the treatment of type 1 diabetes","volume":"2","author":"Acerini","year":"2000","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB202","first-page":"2836","article-title":"Recovery of growth hormone release from suppression by exogenous insulin-like growth factor-I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I","volume":"83","author":"Chapman","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB203","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1172\/JCI117229","article-title":"In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells","volume":"93","author":"Blat","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB204","doi-asserted-by":"crossref","first-page":"11377","DOI":"10.1074\/jbc.270.19.11377","article-title":"Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4","volume":"270","author":"Chernausek","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB205","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1172\/JCI119803","article-title":"Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture","volume":"100","author":"Imai","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB206","first-page":"177","article-title":"Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum","volume":"74","author":"Suikkari","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/joe.0.1350135","article-title":"The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery","volume":"135","author":"Cwyfan Hughes","year":"1992","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB208","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0955-2235(96)00007-5","article-title":"Serum proteolysis of IGFBP-3","volume":"6","author":"Bang","year":"1995","journal-title":"Prog. Growth Factor Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB209","first-page":"1119","volume":"78","author":"Bang","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB210","first-page":"2282","article-title":"Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity","volume":"80","author":"Bereket","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB211","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/endo.134.3.7509737","article-title":"Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma","volume":"134","author":"Lassarre","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB212","first-page":"3284","article-title":"The free form of insulin-like growth factor I increases in circulation during normal human pregnancy","volume":"80","author":"Hasegawa","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB213","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1210\/jcem.83.7.4966","article-title":"Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis","volume":"83","author":"Skj\u00e6rb\u00e6k","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB214","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1006\/bbrc.1993.2389","article-title":"Altered ligand specificity of proteolysed insulin-like growth factor binding protein-3","volume":"196","author":"Baxter","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2004.06.001_BIB215","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1210\/jcem.86.10.7963-1","article-title":"What is the significance of IGF-binding protein-3 proteolysis in the circulation?","volume":"86","author":"Baxter","year":"2001","journal-title":"J Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB216","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj2940847","article-title":"Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum","volume":"294","author":"Baxter","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB217","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJM198707163170303","article-title":"Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults","volume":"317","author":"Guler","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB218","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1464-5491.2003.00827.x","article-title":"The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis","volume":"20","author":"Holt","year":"2003","journal-title":"Diabetes Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB219","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1172\/JCI119438","article-title":"Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors","volume":"99","author":"Di Cola","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0026-0495(96)90056-6","article-title":"Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus","volume":"45","author":"\u00d8rskov","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB221","series-title":"Growth Hormone in Adults, Physiological and Clinical Aspects","first-page":"91","article-title":"Metabolic effects of insulin-like growth factor-I","author":"Hussain","year":"1996"},{"key":"10.1016\/j.ghir.2004.06.001_BIB222","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/00379727-204-43630","article-title":"Regulation and function of insulin-like growth factor-binding protein-1","volume":"204","author":"Lee","year":"1993","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.ghir.2004.06.001_BIB223","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0026-0495(95)90215-5","article-title":"Insulin-like growth factor binding proteins as glucoregulators","volume":"44","author":"Baxter","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB224","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1210\/endo-129-4-2254","article-title":"Insulin-like growth factor-binding protein-1 modulates blood glucose levels","volume":"129","author":"Lewitt","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB225","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1210\/endo.136.9.7544274","article-title":"Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice","volume":"136","author":"Rajkumar","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB226","first-page":"E565","article-title":"Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice","volume":"270","author":"Rajkumar","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB227","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1172\/JCI118982","article-title":"Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice","volume":"98","author":"Rajkumar","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB228","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0167-4889(89)90209-7","article-title":"A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1)","volume":"1011","author":"Carlsson Skwirut","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ghir.2004.06.001_BIB229","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.49.3.457","article-title":"Dysregulation of the insulin\/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance","volume":"49","author":"Crossey","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB230","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1210\/endo.138.5.5143","article-title":"Insulin-like growth factor binding protein-1 induces insulin release in the rat","volume":"138","author":"Mortensen","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB231","first-page":"E352","article-title":"IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates","volume":"272","author":"P\u00f8rksen","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB232","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1210\/endo.135.4.7523094","article-title":"Human insulin-like growth factor-binding protein-1 (hIGFBP-1) in transgenic mice: characterization and insights into the regulation of IGFBP-1 expression","volume":"135","author":"Dai","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB233","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1210\/endo.138.7.5282","article-title":"Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth","volume":"138","author":"Gay","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB234","first-page":"1735","article-title":"The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy","volume":"79","author":"Westwood","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.50.1.32","article-title":"Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice","volume":"50","author":"Sakai","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB236","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1073\/pnas.88.17.7481","article-title":"Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I","volume":"88","author":"Jones","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.06.001_BIB237","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/abbi.1998.0797","article-title":"Phosphorylation of rat insulin-like growth factor binding protein-1 does not affect its biological properties","volume":"357","author":"Peterkofsky","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ghir.2004.06.001_BIB238","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s004670000348","article-title":"The relative importance of endocrine versus autocrine\/paracrine insulin-like growth factor-I in the regulation of body growth","volume":"14","author":"Ohlsson","year":"2000","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB239","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1210\/en.2002-220116","article-title":"Insights from insulin-like growth factor binding protein transgenic mice","volume":"143","author":"Silha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB240","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diabetes.50.5.1110","article-title":"Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity","volume":"50","author":"Yakar","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB241","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1210\/endo.139.10.6273","article-title":"Developmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats","volume":"139","author":"Frystyk","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB242","first-page":"4379","article-title":"Effect of short-term fasting on free\/dissociable insulin-like growth factor-I concentrations in normal human serum.","volume":"81","author":"Bereket","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB243","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1210\/jcem.82.7.4070","article-title":"Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity","volume":"82","author":"Nyomba","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB244","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/oby.2001.83","article-title":"No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance","volume":"9","author":"Ricart","year":"2001","journal-title":"Obes. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB245","first-page":"465","article-title":"Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma","volume":"119","author":"Yeoh","year":"1988","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB246","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/endo.138.3.5020","article-title":"Purification and characterization of the insulin-like growth factor binding protein-1 isoform found in normal plasma","volume":"138","author":"Westwood","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB247","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1046\/j.1365-2265.2003.01791.x","article-title":"The circulating IGF-system and its relationship with 24-hour glucose regulation and insulin sensitivity in healthy subjects","volume":"58","author":"Frystyk","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB248","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jcem-65-3-432","article-title":"Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma","volume":"65","author":"Baxter","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB249","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/00006450-199905010-00021","article-title":"Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children","volume":"45","author":"Heuck","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB250","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1651-2227.2000.tb03343.x","article-title":"Role of IGFBP-1 in glucose regulation","volume":"89","author":"Frystyk","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2004.06.001_BIB251","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jcem-73-5-964","article-title":"Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes","volume":"73","author":"Batch","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB252","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2265.1995.tb02921.x","article-title":"The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1","volume":"43","author":"Cotterill","year":"1995","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB253","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.2337\/diacare.20.9.1442","article-title":"Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM","volume":"20","author":"Kobayashi","year":"1997","journal-title":"Diabetes Care"},{"issue":"Suppl.","key":"10.1016\/j.ghir.2004.06.001_BIB254","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1507\/endocrj.47.SupplMarch_S91","article-title":"A role of free insulin-like growth factor-I in dawn phenomenon in children and adolescents with type 1 diabetes mellitus","volume":"47","author":"Kobayashi","year":"2000","journal-title":"Endocr. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1054\/ghir.1999.0100","article-title":"The pharmacokinetics of free insulin-like growth factor-I in healthy subjects","volume":"9","author":"Frystyk","year":"1999","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB256","first-page":"955","article-title":"Genetics of mouse growth","volume":"42","author":"Efstratiadis","year":"1998","journal-title":"Int. J. Dev. Biol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB257","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj3350193","article-title":"Genetic engineering in mice: impact on insulin signalling and action","volume":"335","author":"Lamothe","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB258","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1096\/fasebj.14.5.629","article-title":"Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins","volume":"14","author":"Schneider","year":"2000","journal-title":"FASEB J."},{"key":"10.1016\/j.ghir.2004.06.001_BIB259","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/edrv.22.6.0452","article-title":"Distinct and overlapping functions of insulin and IGF-I receptors","volume":"22","author":"Nakae","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB260","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/npep.2002.0893","article-title":"Mutant mouse models of insulin-like growth factor actions in the central nervous system","volume":"36","author":"D'Ercole","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ghir.2004.06.001_BIB261","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0196-106","article-title":"Early neonatal death in mice homozygous for a null allele of the insulin receptor gene","volume":"12","author":"Accili","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ghir.2004.06.001_BIB262","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1210\/endo-123-6-2827","article-title":"Growth enhancement of transgenic mice expressing human insulin-like growth factor I","volume":"123","author":"Mathews","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB263","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1210\/endo-127-3-1033","article-title":"Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice","volume":"127","author":"Behringer","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB264","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1993.tb26213.x","article-title":"Expression of insulin-like growth factor-I in transgenic mice","volume":"692","author":"D'Ercole","year":"1993","journal-title":"Ann.N.Y. Acad. Sci."},{"key":"10.1016\/j.ghir.2004.06.001_BIB265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/12631","article-title":"Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling","volume":"23","author":"Withers","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ghir.2004.06.001_BIB266","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(05)80085-6","article-title":"Role of insulin-like growth factors in embryonic and postnatal growth","volume":"75","author":"Baker","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ghir.2004.06.001_BIB267","first-page":"59","article-title":"Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-I) and type 1 IGF receptor (IgfIr)","volume":"75","author":"Liu","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ghir.2004.06.001_BIB268","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1210\/mend.12.9.0162","article-title":"Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre\/loxP system in transgenic mice","volume":"12","author":"Liu","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB269","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diabetes.50.7.1539","article-title":"Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism","volume":"50","author":"Sjogren","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB270","first-page":"E1071","article-title":"Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4","volume":"272","author":"Smith","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB271","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0303-7207(97)00071-3","article-title":"Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues","volume":"130","author":"Thirone","year":"1997","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB272","first-page":"E447","article-title":"Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice","volume":"277","author":"Dominici","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB273","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes","volume":"15","author":"Fernandez","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB274","first-page":"371","article-title":"Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness","volume":"5","author":"LeRoith","year":"2002","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ghir.2004.06.001_BIB275","doi-asserted-by":"crossref","first-page":"12593","DOI":"10.1074\/jbc.270.21.12593","article-title":"Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors","volume":"270","author":"Chang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB276","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1097-2765(00)80155-0","article-title":"A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance","volume":"2","author":"Bruning","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ghir.2004.06.001_BIB277","first-page":"E16","article-title":"Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice","volume":"281","author":"Shefi-Friedman","year":"2001","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB278","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1073\/pnas.120172697","article-title":"Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system","volume":"97","author":"Ueki","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ghir.2004.06.001_BIB279","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB280","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1172\/JCI117636","article-title":"Intravenously injected insulin-like growth factor (IGF) I\/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats","volume":"95","author":"Zapf","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB281","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1210\/endo.143.5.8764","article-title":"Impaired blockade of insulin-like growth factor I (IGF-I)-induced hypoglycemia by IGF binding protein-3 analogue with reduced ternary complex-forming ability","volume":"143","author":"Firth","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB282","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/endo.140.3.6602","article-title":"Regulation of hepatic glycogen in the insulin-like growth factor II-deficient mouse","volume":"140","author":"Lopez","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB283","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1016\/S0021-9258(17)36715-7","article-title":"Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice","volume":"269","author":"Rogler","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB284","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1074\/jbc.271.1.203","article-title":"Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice","volume":"271","author":"Rossetti","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB285","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1210\/endo.142.5.8165","article-title":"Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice","volume":"142","author":"Modric","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB286","first-page":"E937","article-title":"Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice","volume":"283","author":"Silha","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB287","doi-asserted-by":"crossref","first-page":"19448","DOI":"10.1074\/jbc.M200439200","article-title":"Insulin-like growth factor binding protein-3 activates a phosphotyrosine phosphatase","volume":"277","author":"Ricort","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB288","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1210\/endo.140.12.7169","article-title":"Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain","volume":"140","author":"Hoeflich","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2004.06.001_BIB289","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/diabetes.51.7.2313","article-title":"A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations","volume":"51","author":"Frayling","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB290","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00125-002-0951-1","article-title":"Conflicting results on variation in the IGFI gene highlight methodological considerations in the design of genetic association studies","volume":"45","author":"Frayling","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB291","first-page":"1606","article-title":"Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus","volume":"85","author":"Rasmussen","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB292","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2337\/diabetes.52.6.1403","article-title":"Low circulating IGF-II concentrations predict weight gain and obesity in humans","volume":"52","author":"Sandhu","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB293","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2337\/diab.44.5.483","article-title":"Preventing non-insulin-dependent diabetes","volume":"44","author":"Knowler","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB294","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1532-5415.1999.tb07431.x","article-title":"Low plasma insulin-like growth factor-1 concentrations predict worsening of insulin-mediated glucose uptake in older people","volume":"47","author":"Paolisso","year":"1999","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.ghir.2004.06.001_BIB295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/dmrr.178","article-title":"Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians","volume":"17","author":"Barbieri","year":"2001","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB296","first-page":"1935","article-title":"Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children","volume":"83","author":"Travers","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB297","first-page":"E929","article-title":"Effect of training on the GH\/IGF-I axis during exercise in middle-aged men: relationship to glucose homeostasis","volume":"283","author":"Manetta","year":"2002","journal-title":"Am. J. Physiol"},{"key":"10.1016\/j.ghir.2004.06.001_BIB298","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-2265.1999.00647.x","article-title":"Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome","volume":"50","author":"Mohamed-Ali","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB299","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0026-0495(95)90214-7","article-title":"Role of the time factor in signaling specificity: application to mitogenic and metabolic signalling by the insulin and insulin-like growth factor-I receptor tyrosine kinases","volume":"44","author":"De Meyts","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB300","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","article-title":"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells","volume":"19","author":"Frasca","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB301","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1172\/JCI116828","article-title":"Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans","volume":"92","author":"Hussain","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB302","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-0495(98)90189-5","article-title":"Recombinant human insulin-like growth factor-I abolishes changes in insulin requirements consequent upon growth hormone pulsatility in young adults with type I diabetes mellitus","volume":"47","author":"Crowne","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB303","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2337\/diab.45.1.91","article-title":"Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes","volume":"45","author":"Moses","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2004.06.001_BIB304","first-page":"E1360","article-title":"Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects","volume":"282","author":"Pratipanawatr","year":"2002","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB305","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2002-020343","article-title":"IGF-I\/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms","volume":"87","author":"O'Connell","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB306","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/jcem.87.1.8143","article-title":"Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity","volume":"87","author":"Silfen","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB307","first-page":"8601","article-title":"Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?","volume":"61","author":"Hoeflich","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB308","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0026-0495(95)90117-5","article-title":"Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction","volume":"44","author":"Riedel","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2004.06.001_BIB309","first-page":"2509","article-title":"Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: relation to insulin and insulin sensitivity","volume":"83","author":"Bang","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB310","first-page":"E736","article-title":"Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery","volume":"281","author":"Nygren","year":"2001","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB311","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0300-595X(80)80037-5","article-title":"The riddle of tumour hypoglycaemia revisited","volume":"9","author":"Kahn","year":"1980","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB312","first-page":"62","article-title":"The pathophysiology of IGF-II hypersecretion in non-islet cell tumor hypoglycemia","volume":"3","author":"Daughaday","year":"1995","journal-title":"Diabetes Rev."},{"key":"10.1016\/j.ghir.2004.06.001_BIB313","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/1043-2760(94)00144-S","article-title":"Insulinlike growth factor binding proteins and tumor hypoglycemia","volume":"6","author":"Zapf","year":"1995","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB314","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000185023","article-title":"The role of insulin-like growth factors and their binding proteins in tumor hypoglycemia","volume":"46","author":"Baxter","year":"1996","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB315","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1172\/JCI116152","article-title":"Can big insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?","volume":"90","author":"Zapf","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2004.06.001_BIB316","first-page":"2700","article-title":"Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia","volume":"80","author":"Baxter","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB317","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jcem-73-4-696","article-title":"Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors","volume":"73","author":"Baxter","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2004.06.001_BIB318","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF02935648","article-title":"Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of free IGF-II","volume":"3","author":"Daughaday","year":"1995","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2004.06.001_BIB319","first-page":"1534","article-title":"Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors","volume":"39","author":"M\u00f8ller","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2004.06.001_BIB320","first-page":"E1149","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB321","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/abio.1996.0114","article-title":"Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput kinase receptor activation enzyme-linked immunosorbant assay","volume":"235","author":"Sadick","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ghir.2004.06.001_BIB322","first-page":"121","article-title":"Kinase receptor activation (KIRA): a rapid and accurate alternative to endpoint bioassays","volume":"97","author":"Sadick","year":"1999","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.ghir.2004.06.001_BIB323","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1530\/eje.0.1340184","article-title":"Plasma free insulin-like growth factor I concentrations in growth hormone deficiency in children and adolescents","volume":"134","author":"Hasegawa","year":"1996","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB324","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1530\/eje.0.1370132","article-title":"Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement","volume":"137","author":"Skj\u00e6rb\u00e6k","year":"1997","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2004.06.001_BIB325","first-page":"269","article-title":"Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary\u2013gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study","volume":"49","author":"Juul","year":"1998","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2004.06.001_BIB326","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2265.1999.00677.x","article-title":"Evaluation of free insulin-like growth factor-I measurement on the diagnosis and follow-up treatment of growth hormone-deficient adult patients","volume":"50","author":"Musolino","year":"1999","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.ghir.2004.06.001_BIB327","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2002.01485.x","article-title":"Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa","volume":"56","author":"St\u00f8ving","year":"2002","journal-title":"Clin. Endocrinol. (Oxf.)"}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637404001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:40:48Z","timestamp":1761086448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637404001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":327,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S1096637404001236"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2004.06.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free insulin-like growth factors \u2013 measurements and relationships to growth hormone secretion and glucose homeostasis","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2004.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}